Dengue in the Americas and Caribbean: Update 2

The Pan American Health Organization (PAHO) reports continuing widespread transmission of dengue fever in countries of the Americas and the Caribbean.

The following countries have reported dengue cases from 1 January 2024 to 25 May 2024:

Antigua and Barbuda: 41 cases

Argentina: 498 091 cases (343 deaths)

Aruba: 16 cases

Barbados: 1 260 cases

Belize: 524 cases

Bolivia 36 747 cases (14 deaths)

Bonaire, Saint Eustatius and Saba: 207 cases

Brazil: 7 253 599 cases (3 086 deaths)

Cayman Islands: 3 cases

Chile: 148 cases

Colombia: 157 097 cases (70 deaths)

Costa Rica: 8 851 cases

Curaçao: 262 cases

Dominican Republic: 8 663 cases

Ecuador: 27 063 cases (31 deaths)

El Salvador: 2 056 cases

French Guiana: 14 084 (cases)

Grenada: 153 cases (1 death)

Guadeloupe: 3 450 cases

Guatemala: 21 991 cases (10 deaths)

Guyana: 12 929 cases (2 deaths)

Honduras: 20 563 cases (10 deaths)

Jamaica: 1 234 cases

Martinique: 5 360 cases

Mexico: 73 532 cases (26 deaths)

Montserrat: 1 case

Nicaragua: 17 339 cases

Panama: 6 774 cases (12 deaths)

Paraguay: 278 827 cases (100 deaths)

Peru: 242 742 cases (192 deaths)

Puerto Rico: 885 cases

Saint Barthelemy: 122 cases

Saint Kitts and Nevis: 167 cases

Saint Lucia: 7 cases

Saint Martin: 489 cases

Saint Vincent and the Grenadines: 2 cases

Sint Maarten: 115 cases

Suriname: 95 cases (3 deaths)

Trinidad and Tobago: 110 cases

Turks and Caicos Islands: 92 cases

United States of America: 626 cases

Uruguay: 701 (2 deaths)

US Virgin Islands: 6 cases

Advice for Travellers

Dengue is an infection found in tropical and sub-tropical climates worldwide.

All travellers to endemic regions are potentially at risk of dengue fever and should be aware of this infection.

Aedes mosquitoes are particularly persistent and aggressive. They bite between dawn and dusk.

• Prevention relies on avoiding mosquito bites at all times.

Travellers developing a fever during or on return from travel are advised to seek medical attention as soon as possible.

A new dengue vaccine Qdenga® has been licensed in the UK.

• Guidance on the recommended use of Qdenga® vaccine is currently being drafted for the Green Book, but is not yet available.
• In the interim period, please see the JCVI guidance on the safe use of the Qdenga® vaccine

For further information see TRAVAX dengue fever page.